We are live on ! Find out more
VLKIM

Van Lanschot Kempen Investment Management Portfolio holdings

AUM $11.4B
1-Year Est. Return 16.77%
This Fund
S&P 500
This Quarter Est. Return
+12.73%
1 Year Est. Return
+16.77%
3 Year Est. Return
+63.28%
5 Year Est. Return
+82.06%
10 Year Est. Return
+190.54%
AUM
$10.5B
AUM Growth
+$920M
Cap. Flow
-$64.6M
Cap. Flow %
-0.62%
Top 10 Hldgs %
40.97%
Holding
262
New
34
Increased
109
Reduced
86
Closed
23

Top Buys

Rank Stock Value
1
NVR icon
NVR
NVR
+$100M
2
LEN icon
Lennar Class A
LEN
+$88.5M
3
TMO icon
Thermo Fisher Scientific
TMO
+$82.1M
4
LFUS icon
Littelfuse
LFUS
+$65.8M
5
KKR icon
KKR & Co
KKR
+$54M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$150M
2
MDT icon
Medtronic
MDT
+$149M
3
AVTR icon
Avantor
AVTR
+$89.3M
4
MA icon
Mastercard
MA
+$42.5M
5
HBAN icon
Huntington Bancshares
HBAN
+$36.5M

Sector Composition

Rank Sector Weight
1 Technology 28.31%
2 Financials 21.4%
3 Consumer Discretionary 13.45%
4 Communication Services 13.1%
5 Healthcare 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
251
Johnson & Johnson
JNJ
$629B
-904,093
Closed -$150M
MSA icon
252
Mine Safety
MSA
$7.41B
-33,601
Closed -$4.93M
PCG icon
253
PG&E
PCG
$38.3B
-476,707
Closed -$8.19M
REG icon
254
Regency Centers
REG
$13.9B
-1,430
Closed -$105K
SBRA icon
255
Sabra Healthcare REIT
SBRA
$5.16B
-381,329
Closed -$6.66M
SBUX icon
256
Starbucks
SBUX
$124B
-77,079
Closed -$7.56M
SNBR
257
DELISTED
Sleep Number
SNBR
-398,687
Closed -$2.53M
SRE icon
258
Sempra
SRE
$56.2B
-1,605
Closed -$115K
VST icon
259
Vistra
VST
$49.2B
-48,724
Closed -$5.72M
WM icon
260
Waste Management
WM
$90.5B
-51,377
Closed -$11.9M
WMT icon
261
Walmart Inc
WMT
$923B
-80,408
Closed -$7.06M
XYL icon
262
Xylem
XYL
$28.5B
-56,935
Closed -$6.8M

Similar funds

Van Lanschot Kempen Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, Van Lanschot Kempen Investment Management held 262 positions worth $10.5B, up 9.6% from $9.58B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Van Lanschot Kempen Investment Management's Q2 2025 filing shows 34 new, 109 increased, 86 reduced and 23 closed positions. Its largest new stake was NVR: 13,962 shares worth $103M. The largest sale was Johnson & Johnson, an estimated $150M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Van Lanschot Kempen Investment Management's largest Q2 2025 buy was NVR: 13,962 shares worth $103M.
  • Van Lanschot Kempen Investment Management added most to Thermo Fisher Scientific in Q2 2025, an estimated $82.1M increase.
  • Van Lanschot Kempen Investment Management's biggest Q2 2025 reduction was Medtronic, cutting an estimated $149M.
  • Van Lanschot Kempen Investment Management fully exited Johnson & Johnson in Q2 2025, selling an estimated $150M.
  • Van Lanschot Kempen Investment Management's ten largest holdings make up 41% of its $10.5B portfolio in Q2 2025.
  • Van Lanschot Kempen Investment Management opened 34 new positions and closed 23 in Q2 2025.
  • Van Lanschot Kempen Investment Management's portfolio value rose 9.6% quarter-over-quarter to $10.5B.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2025, filed 7 Aug 2025.